Detalhe da pesquisa
1.
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study.
Ann Hematol
; 103(3): 981-992, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092996
2.
Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.
Hematol Oncol
; 40(2): 280-286, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120267
3.
Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies.
Am J Hematol
; 97(6): 802-817, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285978
4.
Selected severe „haematological“ syndromes in adult intensive care patients.
Vnitr Lek
; 68(8): 498-507, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575067
5.
Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2021.
Br J Haematol
; 193(4): 705-722, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216972